Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: Results of a prospective observational study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Bone Marrow Transplantation ; 56 (2020), 3. - S. 692-695. - ISSN 0268-3369. - eISSN 1476-5365
- Ereignis
-
Veröffentlichung
- (wo)
-
Ulm
- (wer)
-
Universität Ulm
- (wann)
-
2020
- Urheber
-
Schetelig, Johannes
Hoek, Jennifer
Stilgenbauer, Stephan
Middeke, Jan Moritz
Andersen, Niels Smedegaard
Fox, Christopher P.
Lenhoff, Stig
Volin, Liisa
Shimoni, Avichai
Schroyens, Wilfried
van Gelder, Michel
Bunjes, Donald
van Biezen, Anja
Baldauf, Henning
de Wreede, Liesbeth C.
Tournilhac, Olivier
Kröger, Nicolaus
Yakoub-Agha, Ibrahim
Dreger, Peter
- DOI
-
10.18725/OPARU-50837
- URN
-
urn:nbn:de:bsz:289-oparu-50913-2
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:49 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Schetelig, Johannes
- Hoek, Jennifer
- Stilgenbauer, Stephan
- Middeke, Jan Moritz
- Andersen, Niels Smedegaard
- Fox, Christopher P.
- Lenhoff, Stig
- Volin, Liisa
- Shimoni, Avichai
- Schroyens, Wilfried
- van Gelder, Michel
- Bunjes, Donald
- van Biezen, Anja
- Baldauf, Henning
- de Wreede, Liesbeth C.
- Tournilhac, Olivier
- Kröger, Nicolaus
- Yakoub-Agha, Ibrahim
- Dreger, Peter
- Universität Ulm
Entstanden
- 2020
Ähnliche Objekte (12)
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation
The role of immune checkpoint molecules for relapse after allogeneic hematopoietic cell transplantation
Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: a multi-centre observational study
Allogeneic hematopoietic stem cell transplantation for congenital immune dysregulatory disorders
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
Novel biomarkers for outcome after allogeneic hematopoietic stem cell transplantation
Pre-emptive allogeneic hematopoietic stem cell transplantation in ataxia telangiectasia
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Cost of hematopoietic stem cell's allogeneic transplantation: an integrative review
Prostaglandin l2 and Caveolin-1 in allogeneic hematopoietic stem cell transplantation
VH1 Family Immunoglobulin Repertoire Sequencing after Allogeneic Hematopoietic Stem Cell Transplantation
Blinatumomab for Acute Lymphoblastic Leukemia Relapse after Allogeneic Hematopoietic Stem Cell Transplantation